Both in Biotechnology
Replimune Group vs Maze Therapeutics
Over the past year REPL returned +89.3% and MAZE returned −5.3%; their daily moves had a correlation of 0.07.
REPL +89.3% MAZE −5.3%Growth of $1, one year, split-adjusted
| Metric | REPL | MAZE |
|---|---|---|
| Price | $17.61 | $31.48 |
| Market cap | $1.67B | $1.75B |
| Today | +1.27% | −1.41% |
| 1 month | +30.9% | +18.1% |
| 6 months | +604.4% | +15.9% |
| Year to date | +81.2% | −24.0% |
| 1 year | — | +0.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 87.4× |
| Net cash | $183.7M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.7% | 66.7% |
| Short % of float | 29.6% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).